|
摘要：
|
|
摘要：肝硬化腹水是肝硬化自然病程中发生的严重事件，为失代偿期肝硬化患者常见
且严重的并发症之一。因此，腹水的防治一直是临床治疗中的难点和研究热点。目前
西医治疗肝硬化腹水，尤其是难治性腹水作用有限，中医在长期临床工作中对消退腹
水、改善患者整体状态等方面有一定优势。随着研究进展及临床经验的不断更新，需
要对中医诊疗方案进行更新。为对腹水及其相关并发症的诊疗和预防工作做出合理决
策，深圳市中医院肝病科依托国家中医药管理局华东南中医肝病诊疗中心联盟，牵头
联合各联盟的肝病专家，经过专业委员会专家的多次反复讨论，基于临床证据及专家
共识意见更新、修订形成了《鼓胀（肝硬化腹水）中医诊疗专家建议》，以满足肝硬
化腹水临床诊治的需要。
|
|
Abstract: Cirrhosis ascites is a significant event that occurs during the natural progression of
cirrhosis and represents a common and serious complication in patients with decompensated
liver cirrhosis. Consequently, the prevention and treatment of ascites have always posed
challenges and remain a prominent research topic in clinical practice. Currently, Western
medicine encounters considerable difficulty in managing cirrhosis ascites, particularly
refractory cases; however, Chinese medicine has demonstrated certain advantages in reducing
ascites and enhancing overall patient condition over long-term clinical experience. With
ongoing research progress and accumulated clinical expertise, it becomes imperative to update
the traditional Chinese medicine (TCM) diagnosis and treatment expert advice accordingly.
In order to make informed decisions regarding the diagnosis and management of ascites as
well as related complications, Department of Liver Disease, Shenzhen Hospital of Traditional
Chinese Medicine collaborated with liver disease experts from various alliances under the
guidance of National Administration of TCM Southeast China Alliance of TCM Hepatology
Diagnosis and Treatment Center. After multiple extensive discussions by expert committees
based on updated clinical evidence and consensus opinions, “TCM diagnosis and treatment
schem of Guzhanag (asctes due to liver cirrhosis)” was evised and updated to cater to the
evolving needs for diagnosing and treating cirrhosis-related ascites.
|
|
基金项目：
|
|
|
|
作者简介：
|
|
|
|
参考文献：
|
|
|
|
服务与反馈：
|
|
【文章下载】【加入收藏】
|
|
|
|